Introduction
Multidrug resistance protein/cystic fibrosis transmembrane conductance regulator (MRP/CFTR) constitutes a subfamily of ATP-binding cassette (ABC) proteins (Human ABC Gene Nomenclature Committee [http://www.gene.ucl. and the anti-human immunodeficiency virus (HIV) drug 9-(2-phosphonylmethoxyethyl)adenine (PMEA) (Schuetz et al. 1999) . Consequently, ABCC4 confers resistance to these drugs. ABCC5 is mainly expressed at high transcript levels in skeletal muscle, brain, and heart, and at a very low level in liver (McAleer et al. 1999 ). This protein acts as the cellular export of cyclic nucleotides and introduces resistance to thiopurine anticancer drugs such as 6-mercaptopurine and thioguanine, and the anti-HIV drug PMEA (Wijnholds et al. 2000) .
CFTR (cystic fibrosis transmembrane conductance regulator) acts as a chloride channel (Bear et al. 1992 ) and also regulates other ion transport pathways including the amiloride-sensitive epithelial sodium channel (Schreiber et al. 1999) . Mutations in the CFTR gene were found in patients with cystic fibrosis (Cystic Fibrosis Mutation Data Base [http://www.genet.sickkids.on.ca/cftr/]) and congenital bilateral absence of the vas deferens (Costes et al. 1995; Zielenski et al. 1995) . CFTR mutations were found at significantly higher frequencies in patients with disseminated bronchiectasis or allergic bronchopulmonary aspergillosis than expected (Miller et al. 1996; Pignatti et al. 1996) .
The sulfonylurea receptor (SUR) contains ATP-sensitive potassium (K ATP ) channels that are involved in many diverse functions such as insulin secretion from pancreatic cells, regulation of skeletal muscle excitability, neurotransmitter release, and smooth muscle relaxation (Quayle et al. 1997) . The SUR subunit consists of two members, ABCC8 (SUR1) and ABCC9 (SUR2). Channels containing isoform ABCC8 (SUR1) found in neuronal cells and pancreatic -cells are closed in response to the sulfonylurea hypoglycemic drugs (Gribble et al. 1998 ) and can be activated by diazoxide (D'hahan et al. 1999) . Mutations and deficiencies in this protein were detected in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion (Thomas et al. 1995; Nestorowicz et al. 1996 Nestorowicz et al. , 1998 Glaser et al. 1999; Verkarre et al. 1998 ). An arginine residue at codon 1273 was reported to be associated with hyperinsulinemia in Mexican American nondiabetic individuals (Goksel et al. 1998 ) and with type 2 diabetes mellitus in French Caucasians (Reis et al. 2000) . ABCC9 (SUR2) is the primary regulatory subunit expressed in muscle cells and generates two splice variants, SUR2A (exon 38a) and SUR2B (exon 38b) (Isomoto et al. 1996) . The SUR2A transcript was predominantly expressed in cardiac and skeletal muscle, whereas the SUR2B transcript was detected mainly in vascular smooth muscle (Isomoto et al. 1996; Davis-Taber et al. 2000) .
To investigate the nature of apparent genotype/ phenotype correlations for some ABC-transporters in more detail, we began by searching for additional singlenucleotide polymorphisms (SNPs) in the eight ABCC genes described earlier, including their promoter regions and introns, except repetitive elements. We report here a total of 779 genetic variations, of which 454 have not been reported before.
Subjects and methods
Total genomic DNAs were isolated from peripheral leukocytes by the standard phenol/chloroform extraction method in 48 unrelated Japanese individuals. Informed consent was obtained from each participant. On the basis of sequence information from GenBank, we designed polymerase chain reaction (PCR) primers to amplify DNA fragments from all eight genes, excluding repetitive elements, by invoking the REPEAT MASKER computer program (http://ftp.genome.washington.edu/cgi-bin/RepeatMasker). PCR experiments and DNA sequencing were performed according to methods described previously Sekine et al. 2001; Saito et al. 2001 ). All SNPs detected by the PolyPhred Computer Program (Nickerson et al. 1997) were confirmed by sequencing both strands of each PCR product.
Results
Exon-intron boundaries of the eight genes were defined by comparison of genomic sequences with cDNA sequences. Accession numbers of the genomic and cDNA sequences used for this study are listed in Table 1 . We screened 96 Japanese chromosomes for SNPs in the eight ABCC genes by means of direct DNA sequencing. Figure 1 (a-h) illustrates the location of each variation in the respective genes; detailed information for nucleotide positions and substitutions is summarized in Table 2 (a-h). Resequencing of a total of about 423 kb of genomic DNA (37.7 kb for the ABCC1 gene, 38.0 kb for ABCC2, 26.4 kb for ABCC3, 97.7 kb for ABCC4, 39.6 kb for ABCC5, 79.4 kb for CFTR, 50.0 kb for ABCC8, and 53.9 kb for ABCC9) identified a total of 688 SNPs and 91 insertion/ deletion polymorphisms, as summarized in Table 3 . On average, we identified 1 SNP in every 614 nucleotides. Four hundred fifty-four (58%) of the 779 genetic variations identified in our screening (including insertion/deletion polymorphisms) were not reported previously.
Among the 688 SNPs, 6 were located in the 5Ј flanking regions, 617 in introns, 46 in exons, and 19 in 3Ј flanking regions (Table 4) . Among the 46 SNPs detected in exons, 3 were located in the 5Ј untranslated region (UTR), 36 in coding regions, and 7 in 3ЈUTR. Of the 36 SNPs detected in the coding regions, 10 SNPs would cause substitution of an amino acid and 6 of them are novel. Among the 26 synonymous SNPs, 7 are novel (Table 5) .
Tables 6 and 7 summarize the 39 genetic variations that are present in the regions surrounding the exon-intron junctions and that might introduce alternative splicing or influence the splicing machinery. Two polymorphisms (intron 19 ϩ 3383 in the ABCC1 gene, and intron 12 ϩ 85 in ABCC3) were located within the putative branch point consensus sequence.
Discussion
We identified 779 genetic variations (688 SNPs and 91 insertion/deletion polymorphisms) by screening the entire genomic regions, except for repetitive sequences, encoding eight ABCC genes (ABCC1, ABCC2, ABCC3, ABCC4, ABCC5, CFTR, ABCC8, and ABCC9) in 48 unrelated Japanese individuals. Polymorphisms published here should be useful for examining the relationships between genotypes and susceptibility to certain diseases as well as for examining the efficacy or adverse effects of certain drugs. Among the six novel nonsynonymous polymor- We identified many genetic variations within the intronic regions flanking the exon-intron junctions. These regions contained unique branch point sequences that are located 6-59 nucleotides upstream of the splice acceptor site and have the RNA consensus sequence YNYURAC (Y ϭ C or T; R ϭ G or A; N ϭ any base) (Maquat 1996) . A at position 6 in this consensus is critical for formation of a mammalian splice intermediate, the lariat structure. In addition, it has been shown that mutation of this A residue strongly reduces splicing efficiency of the downstream exon (Reed and Maniatis 1988) . Two polymorphisms (Intron 19 ϩ 3383 in the ABCC1 gene, and Intron 12 ϩ 85 in ABCC3) that we found are located within the putative branch point consensus sequence. Because these polymorphisms are located next to the A residue, these variants might influence mRNA processing.
In introns of most mammalian genes, the polypyrimidine tract near the splice acceptor site is highly conserved and plays a central role in aiding the splice branch site recognition, and in identifying and using the splice acceptor site (Smith et al. 1989; Reed 1989) . For example, the deletion of the polypyrimidine tract inhibits spliceosome assembly and lariat formation (Reed and Maniatis 1985; Ruskin and Green 1985) . In the CFTR gene, there were sequence variations of the TG dinucleotide repeats immediately followed by the polythymidine (poly-T) tract at the splice branch/ acceptor site of exon 9 (although this exon was reported to be exon 9, it is in fact exon 10) (Chu et al. 1991) . Although polymorphisms were reported in both the TG dinucleotide repeat and the poly-T tract in the Caucasian population, we found no polymorphism within the poly-T tract in the Japanese population. Chu et al. (1993) demonstrated that the shorter the poly-T tract at exon 9 splice/branch acceptor site of the CFTR gene, the higher the proportion of inframe skipping of exon 9 in the transcript of the respiratory epithelium. Moreover, Cuppens et al. (1998) found that TG dinucleotide-repeat polymorphism independently affected the amount of the CFTR transcript lacking exon 9. A longer Chu et al. (1993) c SNP previously reported by Cuppens et al. (1998) TG repeat would place the branchpoint A nucleotide of the lariat in a less favorable position for splicing. Hence, some of these polymorphisms found near the exon-intron junctions might influence posttranscriptional processing of the transcripts.
In conclusion, these genetic variations should contribute to studies that investigate possible correlations of genotypes with disease-susceptibility phenotypes, and responsiveness or adverse effects to drugs. All data for the genetic variations reported here are available through our website (http:/ /snp.ims.u-tokyo.ac.jp/).
